Please login to the form below

Not currently logged in
Email:
Password:

EC approves Pegasys

Roche has revealed that the European Commission approved its hepatitis C medicine, Pegasys. The company says the drug could lead to patients being cured in four months
Roche has revealed that the European Commission (EC) approved its hepatitis C medicine, Pegasys. The company says the drug could lead to patients being cured in four months.

It has been developed as a 16-week treatment for the genotype 2 and 3 strains of hepatitis C in patients with low virus levels. The company hopes that the shorter treatment rates will reduce patients' exposure to drug therapies.

Previous to the approval of Pegasys, patients had to undergo 24 weeks of treatment, even if they had low virus levels and rapid response rates to the medicine.

William Burns, CEO of Roche pharmaceuticals division, explained that the company is committed to advancing the use of personalised medicine, which accounts for patients' reaction and medical history.

"This approval for 16 weeks of treatment in genotype 2 and 3 patients with a rapid response demonstrates the value of using diagnostic tools to determine an individual treatment regime and hopefully will encourage more eligible patients to come forward for treatment," he said.

26th June 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
...
Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...

Infographics